Artivion, Inc. (AORT) is a publicly traded Healthcare sector company. As of September 11, 2026, AORT trades at $25.08 with a market cap of $1.20B and a P/E ratio of -496.30. AORT moved +1.74% today. Year to date, AORT is -43.59%; over the trailing twelve months it is -40.72%. Its 52-week range spans $19.16 to $48.25. Analyst consensus is strong buy with an average price target of $41.87. Rallies surfaces AORT's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Rallies tracks politician and congressional stock disclosures for AORT, including purchases, sales, transaction dates, owners, and reported trade amounts when available.
| Metric | Value |
|---|---|
| Price | $25.08 |
| Market Cap | $1.20B |
| P/E Ratio | -496.30 |
| EPS | $-0.05 |
| Dividend Yield | 0.03% |
| 52-Week High | $48.25 |
| 52-Week Low | $19.16 |
| Volume | 415.01K |
| Avg Volume | 0 |
| Revenue (TTM) | $471.47M |
| Net Income | $-3.17M |
| Gross Margin | 64.37% |
6 analysts cover AORT: 0 strong buy, 6 buy, 0 hold, 0 sell, 0 strong sell. Consensus rating is strong buy. Average price target: $41.87.